• Medpacto inks deal with AstraZeneca biospectrumasia
    August 03, 2018
    Under the terms of the agreement, MedPacto and AstraZeneca will collaborate on a non-exclusive basis to evaluate the combination of the two drugs in NSCLC
PharmaSources Customer Service